secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tevogen Bio Holdings Inc. (TVGN)
CIK:        0001860871
Form:       8-K
Filed at:   2023-05-09T23:59:59+00:00
Accession:  0001104659-23-057818
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SPAC Semper Paratus enters subscription and purchase agreements; cures Nasdaq delinquency
--------------------------------------------------------------------------------

- Subscription Agreement with Polar Multi-Strategy Master Fund for $151k capital; SPAC will issue 151k Class A shares at de-SPAC close.
- Purchase Agreement with SSVK Associates for $1: acquires 7,988,889 Class A shares and 1M private placement units; SSVK assumes SPAC obligations.
- SSVK may replace directors/officers; deal conditions include board approval, underwriter consent, filing of Q1 2023 10-Q.
- Nasdaq delisting risk cured after paying $151k fee; company now compliant and securities continue trading.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860871/000110465923057818/0001104659-23-057818-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860871/000110465923057818/tm2315115d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-057818

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer